Lots of assumptions at this stage but my reasoning is as...

Lots of assumptions at this stage but my reasoning is as follows.
In the third year of the Labcon contract, the agreed minimum contract volume is around $10M (AUD). I think that could contribute $5M to PBT or around $4M NPAT. I would further expect that the companies growth rate would lead to them having a PE of around 25 which would allow for a market cap of $100M and a share price double what it is today, say 20c. Any other contract success would only increase the share price (certainly in the short term) but may also put pressure on their ability to deliver, so there could be some weakness down the track as, for example, they may need a CR to increase capacity to meet demand.